Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Retained Earnings (2022 - 2025)

Praxis Precision Medicines has reported Retained Earnings over the past 4 years, most recently at -$1.1 billion for Q4 2025.

  • Quarterly results put Retained Earnings at -$1.1 billion for Q4 2025, down 31.46% from a year ago — trailing twelve months through Dec 2025 was -$1.1 billion (down 31.46% YoY), and the annual figure for FY2025 was -$1.1 billion, down 31.46%.
  • Retained Earnings for Q4 2025 was -$1.1 billion at Praxis Precision Medicines, down from $500000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for PRAX hit a ceiling of $1.3 million in Q3 2024 and a floor of -$1.1 billion in Q4 2025.
  • Median Retained Earnings over the past 4 years was -$530.6 million (2022), compared with a mean of -$487.0 million.
  • Biggest five-year swings in Retained Earnings: surged 100.21% in 2024 and later tumbled 1376238.03% in 2025.
  • Praxis Precision Medicines' Retained Earnings stood at -$530.6 million in 2022, then dropped by 23.23% to -$653.9 million in 2023, then decreased by 27.96% to -$836.7 million in 2024, then crashed by 31.46% to -$1.1 billion in 2025.
  • The last three reported values for Retained Earnings were -$1.1 billion (Q4 2025), $500000.0 (Q3 2025), and -$977.2 million (Q2 2025) per Business Quant data.